Nachrichten zur Teva Pharmaceutical Industries Limited Aktie

Teva Pharmaceutical Shares Slide 12% on 1Q Earnings Miss

Teva Pharmaceutical Shares Slide 12% on 1Q Earnings Miss...…

Teva Pharm Q1 net profit slides, maintains 2023 forecast

...JERUSALEM (Reuters) -Israel-based Teva Pharmaceutical Industries......…

Teva misses on profit, beats analysts on revenue

The Israeli company reported non-GAAP earning per share of just $0.40, while market expectations were $0.56....…

UPDATE 1-Teva Pharm Q1 net profit slides, maintains 2023 forecast

... (Reuters) - Israel-based Teva Pharmaceutical Industries reported a drop......…

ROUNDUP: Teva Pharma Reaffirms FY23 Outlook

PETAH TIKVA (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed…

Teva Pharm Q1 net profit slides, revenue flat

...JERUSALEM, May 10 (Reuters) - Israel-based Teva Pharmaceutical......…

Teva Pharmaceutical Industries Limited Q1 Earnings Summary

PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$205 million in Q1 vs.…

Form 8-K TEVA PHARMACEUTICAL INDU For: May 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical Q1 results in focus with eye on revenue numbers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA approves innovative Teva schizophrenia drug

UZEDY was developed together with MedinCells copolymer technology....…

Teva, MedinCell win FDA nod for long-acting schizophrenia therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Recalls FENTANYL Buccal Tablets CII

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to…

Teva Recalls FENTANYL Buccal Tablets CII

Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing…

Teva paid top executives $330m while share price tanked

Over the past 10 years, Teva has paid its top five executives huge amounts while its share price fell 72%....…

Kare Schultz earned $107m during Teva tenure

Schultz who stepped down at the end of 2022 after five years at the helm will receive a further $16…

Teva: Das macht die Aktie für gewisse Anleger interessant

Die Teva-Aktie (WKN: 883035) ist in den letzten Tagen um -13% auf aktuell 7,50 € eingebrochen. Ein aktueller Grund hierfür…

Teva Shares Drop 11% After Alvotech Gets FDA Complete Response Letter

Teva Shares Drop 11% After Alvotech Gets FDA Complete Response Letter...…

Teva down 2%after receiving FDA response letter for AVT02 biologics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva in pact with Neurocrine to delay Ingrezza generics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corporate News: ART MEDICAL

ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units...…

ART MEDICAL Ltd: ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units

ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel…

Teva ends enrollment in late-stage Austedo cerebral palsy trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K TEVA PHARMACEUTICAL INDU For: Mar 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical launches additional dosage strengths of generic Revlimid

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Exec. VP, European Commercial verkauft Aktien von Teva Pharma Industries im Wert von 178.776$

Daniell, Richard - Vorstand - Tag der Transaktion: 2023-03-06...…

Insiderhandel: Exec. VP, European Commercial verkauft Aktien von Teva Pharma Industries im Wert von 509.173$

Daniell, Richard - Vorstand - Tag der Transaktion: 2023-03-07...…

Better Generics Pharmaceutical Stock: Teva or Viatris?

Both have plans to return to growth....…

Form 8-K TEVA PHARMACEUTICAL INDU For: Mar 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Executive VP Global Operations verkauft Aktien von Teva Pharma Industries im Wert von 333.030$

Drape, Eric - Vorstand - Tag der Transaktion: 2023-02-28...…

Insiderhandel: Exec. VP Chief Legal Officer verkauft Aktien von Teva Pharma Industries im Wert von 626.642$

Stark, David Matthew - Vorstand - Tag der Transaktion: 2023-02-28...…

Insiderhandel: EVP, North America Commercial verkauft Aktien von Teva Pharma Industries im Wert von 589.785$

Dethlefs, Sven - Vorstand - Tag der Transaktion: 2023-02-28...…

Insiderhandel: Exec. VP, European Commercial verkauft Aktien von Teva Pharma Industries im Wert von 437.502$

Daniell, Richard - Vorstand - Tag der Transaktion: 2023-02-28...…

Teva announces debt recycling measures

The Israeli pharmaceutical company is to issue $2.06 billion of sustainability-linked senior notes and has begun tender offers to purchase…

Teva to raise $2.06B in sustainability-linked senior notes offering, launches $2.25B in debt tender offers for notes

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Announces $2.06 Bln Senior Notes Offering, $2.25 Bln Debt Tender Offers For Notes

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced Monday its intention to issue $2.06 billion equivalent of sustainability-linked…

Teva: Was Deutschland-Chef Andreas Burkhardt am snowboarden so liebt

Snowboarder sitzen nur am Hang rum und schieben den Schnee nach unten? Mit diesem Vorurteil kann Andreas Burkhardt, Deutschland-Chef von…

Teva Gets FDA Approval for Movement Disorders Treatment

Teva Gets FDA Approval for Movement Disorders Treatment...…

Protein Inhibitors Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche,…

Teva Unveils Spring 2023 Collection

GOLETA, Calif., Feb. 16, 2023 /PRNewswire/ -- Teva®, a division of Deckers Brands (NYSE: DECK), announces the arrival of its…

Global Digital Respiratory Devices Market Report to 2030 - Featuring Cohero Health, Cognita Labs, Adherium, Amiko Digital Health and Teva Pharmaceuticals Industries Among Others

DUBLIN, Feb. 13, 2023 /PRNewswire/ -- The "Digital Respiratory Devices Market Size, Share & Trends Analysis Report by Product (Smart…

dpa-AFX ProFeed